GlaxoSmithKline (GSK) Tops Q3 EPS by 1c

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of GBP0.33, GBP0.01 better than the analyst estimate of GBP0.32. Revenue for the quarter came in at GBP7.84 billion versus the consensus estimate of GBP7.86 million.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
• Surf Air Mobility names Palantir veteran as president of SurfOS